Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM [Phase 3]

View source ↗

Summary

Cytokinetics reports completion of a Phase 3 trial evaluating aficamten versus placebo in adults with symptomatic obstructive hypertrophic cardiomyopathy and no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• Aficamten (aficamten)

Snippet

Sponsor: Cytokinetics | Conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM) | Phase 3 | Status: COMPLETED | Results posted: 2026-03-03